This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Varian Medical's CEO Presents At Bank Of America Merrill Lynch Healthcare Conference Call (Transcript)

Varian Medical Systems, Inc. (VAR)

Bank of America Merrill Lynch Health Care Conference Call

May 15, 2012 04:00 pm ET

Executives

Elisha W. Finney – Corporate Executive Vice President, Finance and Chief Financial Officer

Spencer R. Sias – Vice President, Corporate Communications and Investor Relations

Analysts



Presentation



Unidentified Analyst

[Call Starts Abruptly]

Analyst at B of A. And here with me from Varian, we have Elisha Finney, the CFO, and Spencer Sias, the Head of Investor Relations. Elisha's is going to go ahead and speak for 15 minutes or so, and then we will open it up for Q&A.

Elisha W. Finney

Thank you, [Lenux]. What we thought we would do is just give a brief summary this afternoon and then make sure we leave time to answer any questions that you might have. I will be making some forward-looking statements. Varian's mission is focusing energy on saving lives. And in all three of our business segments, we focus x-ray energy. In Oncology Systems, we focus our energy on tumors, so that we can kill cancer and kill patients. In the X-ray Products Division, we focus energy on better diagnosis, so that you can be diagnosed earlier.

And then finally, in our Security and Inspection Products business, we are focusing energy on inspecting cargo and having safer borders and ports. The mission or the goal of the company is to save an additional 100,000 life each and every year. We treat about over 2 million patients per year, and we are all at the company very dedicated to reaching this goal.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,758.85 -121.51 -0.72%
S&P 500 1,955.25 -14.82 -0.75%
NASDAQ 4,428.1830 -34.7190 -0.78%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs